Jeffrey Townsend

Elihu Professor of Biostatistics

Yale School of Public Health

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Jeffrey Townsend is the Elihu Professor of Biostatistics at the Yale School of Public Health, Yale University, USA. His research areas include cancer genomics, immunotherapy, gene expression evolution, and public health responses to the COVID-19 pandemic. He has contributed to various recent publications examining the relationship between tumor mutation burden and immunotherapy, precision in resistance mutations, and the impact of vaccination strategies on disease transmission.

Articles (19)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (7)

Lajos Pusztai

Yale University

UNITED STATES

View details

Oded Yarden

ISRAEL

View details

Yuval Kluger

Yale University

UNITED STATES

View details

Vincent Cannataro

Assistant Professor

Emmanuel College

UNITED STATES

View details

J. Nick Fisk

Assistant Professor in Computational Biology and Discipline-Based Education Research

University of Rhode Island

UNITED STATES

View details

Wonyong Kim

Sunchon National University

SOUTH KOREA

View details

Alex Dornburg

University of North Carolina

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jeffrey Townsend

Research Interests

Explore related searches

Contact this professor

About

Articles (19)

KRAS G12C-associated immunotherapy benefit in NSCLC is substantially mediated by tobacco-induced tumor mutation burden, not allele-specific effects

Rates of Evolution of Developmental Changes in Gene Expression in Sordariomycetes

Precision projections of the delay of resistance mutations in non-small cell lung cancer via suppression of APOBEC

Optimal Annual COVID-19 Vaccine Boosting Dates Following Previous Booster Vaccination or Breakthrough Infection

Transcription factor-dependent regulatory networks of sexual reproduction in Fusarium graminearum

Origins of lineage‐specific elements via gene duplication, relocation, and regional rearrangement in Neurospora crassa

Sufficient COVID-19 quarantine and testing on international travelers to forestall cross-border transmission after China's removal of the zero-COVID policy in early 2023

Rare Drivers at Low Prevalence with High Cancer Effects in T-Cell and B-Cell Pediatric Acute Lymphoblastic Leukemia

Estimation of Neutral Mutation Rates and Quantification of Somatic Variant Selection Using cancereffectsizeR

Infection with alternate frequencies of SARS-CoV-2 vaccine boosting for patients undergoing antineoplastic cancer treatments

Infection by SARS‐CoV‐2 with alternate frequencies of mRNA vaccine boosting

Seasonality of endemic COVID-19

Not only mutations but also tumorigenesis can be substantially attributed to DNA damage from reactive oxygen species in RUNX1::RUNX1T1-fusion-positive acute myeloid leukemia

Cancer Relevance of Human Genes

Jot: guiding journal selection with suitability metrics

In Response to “De Novo KRAS G12C-Mutant SCLC: A Case Report”

The durability of natural infection and vaccine-induced immunity against future infection by SARS-CoV-2

Secondary Metabolism Gene Clusters Exhibit Increasingly Dynamic and Differential Expression during Asexual Growth, Conidiation, and Sexual Development in Neurospora crassa

Transcriptional Divergence Underpinning Sexual Development in the Fungal Class Sordariomycetes

Collaborators (7)

Lajos Pusztai

Oded Yarden

Yuval Kluger

Vincent Cannataro

J. Nick Fisk

Wonyong Kim

Alex Dornburg

Make your next move.